Aura Biosciences, Inc. (AURA) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 118.5M | 149.74M | 170.12M | 183.96M | 134.52M | 160.62M | 183.48M | 195.6M | 212.25M | 231.79M | 153.89M | 166.21M |
| Cash & Short-Term Investments | 114.73M | 144.24M | 161.87M | 177.31M | 127.99M | 151.09M | 174.38M | 187.42M | 202.87M | 226.15M | 149.06M | 162.01M |
| Cash Only | 84.79M | 59.52M | 47.55M | 107.37M | 38.23M | 31.69M | 25.41M | 30.07M | 26.28M | 41.06M | 55.58M | 47.73M |
| Short-Term Investments | 29.94M | 84.73M | 114.31M | 69.94M | 89.77M | 119.4M | 148.97M | 157.34M | 176.59M | 185.09M | 93.47M | 114.28M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 3.77M | 5.5M | 6.1M | 6.65M | 1.77M | 1.83M | 3.42M | 7.48M | 2.29M | 3.83M | 4.51M | 3.33M |
| Total Non-Current Assets | 19.17M | 19.69M | 19.9M | 20.44M | 20.88M | 21.88M | 21.86M | 22.69M | 22.78M | 23.28M | 25.88M | 26.53M |
| Property, Plant & Equipment | 17.89M | 18.45M | 18.86M | 19.49M | 20.12M | 20.59M | 21.07M | 21.48M | 21.55M | 22M | 24.43M | 25.06M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 768K | 0 | 0 | 768K | 0 | 768K | 0 | 0 | 0 |
| Other Non-Current Assets | 1.28M | 1.24M | 1.04M | 185K | 768K | 1.29M | 22K | 1.21M | 453K | 1.28M | 1.45M | 1.47M |
| Total Assets | 137.68M | 169.43M | 190.02M | 204.4M | 155.4M | 182.5M | 205.34M | 218.28M | 235.03M | 255.07M | 179.77M | 192.74M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -11.41% | -7.16% | -7.46% | -6.36% | -33.88% | -28.45% | 14.23% | 13.25% | 14.08% | 13.91% | 25.58% | 42.75% |
| Total Current Liabilities | 16.71M | 18.38M | 18.82M | 14.85M | 12.16M | 14.91M | 14.71M | 10.55M | 9.66M | 12.36M | 10.89M | 8.89M |
| Accounts Payable | 2.57M | 1.55M | 1.89M | 1.29M | 2.01M | 2.3M | 1.99M | 1.46M | 1.93M | 1.79M | 1.49M | 553K |
| Days Payables Outstanding | 676.97 | - | - | 499.29 | - | 678.93 | - | - | 553.14 | 465.25 | - | - |
| Short-Term Debt | 3.27M | 3.24M | 0 | 0 | 0 | 0 | 0 | 0 | 2.74M | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 10.87M | 13.59M | 152K | 10.37M | 3.17M | 618K | 5.43M | 768K | 3.19M | 935K | 1.02M | 766K |
| Current Ratio | 7.09x | 8.15x | 9.04x | 12.39x | 11.06x | 10.77x | 12.47x | 18.54x | 21.97x | 18.76x | 14.13x | 18.69x |
| Quick Ratio | 7.09x | 8.15x | 9.04x | 12.39x | 11.06x | 10.77x | 12.47x | 18.54x | 21.97x | 18.76x | 14.13x | 18.69x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 13.72M | 14.13M | 14.53M | 14.92M | 15.27M | 15.62M | 15.96M | 16.28M | 16.58M | 16.87M | 17.15M | 17.41M |
| Long-Term Debt | 13.72M | 14.13M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 14.53M | 14.92M | 15.27M | 15.62M | 15.96M | 16.28M | 16.58M | 16.87M | 17.15M | 17.41M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 30.43M | 32.52M | 33.36M | 29.77M | 27.43M | 30.53M | 30.67M | 26.83M | 26.24M | 29.23M | 28.05M | 26.3M |
| Total Debt | 16.99M | 17.38M | 17.75M | 18.11M | 18.44M | 18.77M | 19.08M | 19.03M | 19.32M | 19.56M | 20.19M | 20.41M |
| Net Debt | -67.8M | -42.14M | -29.8M | -89.25M | -19.78M | -12.92M | -6.32M | -11.04M | -6.96M | -21.51M | -35.4M | -27.32M |
| Debt / Equity | 0.16x | 0.13x | 0.11x | 0.10x | 0.14x | 0.12x | 0.11x | 0.10x | 0.09x | 0.09x | 0.13x | 0.12x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 107.25M | 136.91M | 156.67M | 174.63M | 127.97M | 151.97M | 174.67M | 191.45M | 208.78M | 225.85M | 151.72M | 166.44M |
| Equity Growth % | -16.19% | -9.91% | -10.31% | -8.79% | -38.71% | -32.71% | 15.13% | 15.03% | 15.82% | 15.47% | 31.87% | 28.93% |
| Book Value per Share | 1.59 | 2.27 | 2.38 | 3.01 | 2.55 | 3.06 | 3.52 | 3.86 | 4.22 | 5.08 | 3.97 | 4.40 |
| Total Shareholders' Equity | 107.25M | 136.91M | 156.67M | 174.63M | 127.97M | 151.97M | 174.67M | 191.45M | 208.78M | 225.85M | 151.72M | 166.44M |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -514.1M | -480.42M | -454.86M | -428.73M | -401.71M | -374.23M | -348.39M | -327.35M | -307.01M | -287.31M | -265.18M | -246.66M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -207K | -102K | 69K | 25K | 105K | 263K | 607K | -183K | 18K | 539K | -134K | -223K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |